Cargando…

Pharmacology of Herbal Sexual Enhancers: A Review of Psychiatric and Neurological Adverse Effects

Sexual enhancers increase sexual potency, sexual pleasure, or libido. Substances increasing libido alter the concentrations of specific neurotransmitters or sex hormones in the central nervous system. Interestingly, the same pathways are involved in the mechanisms underlying many psychiatric and neu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brunetti, Pietro, Lo Faro, Alfredo Fabrizio, Tini, Anastasio, Busardò, Francesco Paolo, Carlier, Jeremy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602496/ https://www.ncbi.nlm.nih.gov/pubmed/33066617 http://dx.doi.org/10.3390/ph13100309

Ejemplares similares

Development and validation of a fast ultra‐high‐performance liquid chromatography tandem mass spectrometry method for determining carbonic anhydrase inhibitors and their metabolites in urine and hair
por: Lo Faro, Alfredo Fabrizio, et al.
Publicado: (2021)

Usefulness of Oral Fluid for Measurement of Methylone and Its Metabolites: Correlation with Plasma Drug Concentrations and the Effect of Oral Fluid pH
por: Sprega, Giorgia, et al.
Publicado: (2023)

Quantification of Carbonic Anhydrase Inhibitors and Metabolites in Urine and Hair of Patients and Their Relatives
por: Lo Faro, Alfredo Fabrizio, et al.
Publicado: (2022)

Herbal Preparations of Medical Cannabis: A Vademecum for Prescribing Doctors
por: Brunetti, Pietro, et al.
Publicado: (2020)

Medicinal Cannabis and Synthetic Cannabinoid Use
por: Pichini, Simona, et al.
Publicado: (2020)

Cannabidiol, ∆(9)-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients
por: Pigliasco, Federica, et al.
Publicado: (2022)

Ultra-High-Performance Liquid Chromatography Tandem Mass Spectrometry Assay for Determination of Endogenous GHB and GHB-Glucuronide in Nails
por: Busardò, Francesco Paolo, et al.
Publicado: (2018)

Toxicology and Analysis of Psychoactive Tryptamines
por: Malaca, Sara, et al.
Publicado: (2020)

Correlation between Blood and Oral Fluid Psychoactive Drug Concentrations and Cognitive Impairment in Driving under the Influence of Drugs
por: Busardò, Francesco Paolo, et al.
Publicado: (2018)

Non-allowed Pharmacologically Active Substances in Physical and Sexual Performance Enhancing Products
por: Pellegrini, Manuela, et al.
Publicado: (2017)

Adverse Psychiatric Effects Associated with Herbal Weight-Loss Products
por: Bersani, F. Saverio, et al.
Publicado: (2015)

Gamma-hydroxybutyrate Abuse: Pharmacology and Poisoning and Withdrawal Management
por: Marinelli, Enrico, et al.
Publicado: (2020)

New Psychoactive Substances Intoxications and Fatalities during the COVID-19 Epidemic
por: Lo Faro, Alfredo Fabrizio, et al.
Publicado: (2023)

Metabolism Study of Anamorelin, a GHSR1a Receptor Agonist Potentially Misused in Sport, with Human Hepatocytes and LC-HRMS/MS
por: Gameli, Prince Sellase, et al.
Publicado: (2023)

Intensive and pharmacological care in times of COVID-19: A “special ethics” for emergency?
por: Marinelli, Enrico, et al.
Publicado: (2020)

Editorial: Drug-drug interactions in pharmacology
por: Pichini, Simona, et al.
Publicado: (2023)

Designer Benzodiazepines: A Review of Toxicology and Public Health Risks
por: Brunetti, Pietro, et al.
Publicado: (2021)

α-Methyltryptamine (α-MT) Metabolite Profiling in Human Hepatocyte Incubations and Postmortem Urine and Blood
por: Malaca, Sara, et al.
Publicado: (2023)

Use of Methylphenidate Analogues as Cognitive Enhancers: The Prelude to Cosmetic Neurology and an Ethical Issue
por: Zaami, Simona, et al.
Publicado: (2020)

A serious nightmare: psychiatric and neurologic adverse reactions to mefloquine are serious adverse reactions
por: Nevin, Remington L.
Publicado: (2017)

Methylone and MDMA Pharmacokinetics Following Controlled Administration in Humans
por: Poyatos, Lourdes, et al.
Publicado: (2022)

Editorial: Psychiatric and Pharmacotoxicological Insights on Appearance and Performance Enhancing Drugs
por: Zaami, Simona, et al.
Publicado: (2022)

Editorial: The Challenge Posed by New Synthetic Opioids: Pharmacology and Toxicology
por: Pichini, Simona, et al.
Publicado: (2019)

Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry Assay for Quantifying Fentanyl and 22 Analogs and Metabolites in Whole Blood, Urine, and Hair
por: Busardò, Francesco Paolo, et al.
Publicado: (2019)

Pyrrolidinyl Synthetic Cathinones α-PHP and 4F-α-PVP Metabolite Profiling Using Human Hepatocyte Incubations
por: Carlier, Jeremy, et al.
Publicado: (2020)

Sweat Testing for the Detection of Methylone after Controlled Administrations in Humans
por: Di Giorgi, Alessandro, et al.
Publicado: (2023)

GHB Pharmacology and Toxicology: Acute Intoxication, Concentrations in Blood and Urine in Forensic Cases and Treatment of the Withdrawal Syndrome
por: Busardò, Francesco P., et al.
Publicado: (2015)

Has GBL Replaced GHB in Recreational Settings?
por: Tini, Anastasio, et al.
Publicado: (2020)

Psychiatric Aspects of Neurologic Disease
por: Pincus, Jonathan H.
Publicado: (1977)

Are neurological and psychiatric disorders different?()
por: David, Anthony S., et al.
Publicado: (2015)

MELAS can be psychiatric and neurological
por: Finsterer, Josef, et al.
Publicado: (2018)

Human Hepatocyte 4-Acetoxy-N,N-Diisopropyltryptamine Metabolite Profiling by Reversed-Phase Liquid Chromatography Coupled with High-Resolution Tandem Mass Spectrometry
por: Malaca, Sara, et al.
Publicado: (2022)

Fourth generation of synthetic cannabinoid receptor agonists: a summary on the latest insights
por: Malaca, Sara, et al.
Publicado: (2021)

Pharmacovigilance on sexual enhancing herbal supplements
por: Bhagavathula, Akshaya Srikanth, et al.
Publicado: (2016)

Sexual pharmacology
Publicado: (1993)

Synapse Pathology in Psychiatric and Neurologic Disease
por: van Spronsen, Myrrhe, et al.
Publicado: (2010)

Role of Infection in Neurologic and Psychiatric Diseases
por: Solbrig, Marylou V., et al.
Publicado: (2010)

Concomitant Psychiatric Symptoms in Neurological Outpatients
por: Kim, Jarim, et al.
Publicado: (2019)

Proline Metabolism in Neurological and Psychiatric Disorders
por: Yao, Yuxiao, et al.
Publicado: (2022)

Psychiatric and neurological complications of long COVID
por: Zawilska, Jolanta B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jkhd0ihol0s44iu2uv5nrbk7i3